Big Pharma in China: New Opportunities

China’s commitment to universal healthcare in the past 10 years combined with more favorable regulations towards foreign firms has created opportunity for successful pharmaceutical R&D in China by foreign multinationals. New Opportunities for Pharmceuticals “Healthy China 2020” represents the Chinese government’s commitment to bringing universal healthcare coverage by the year 2020.  Since its implementation in […]

Read More